【主题教育·建新功】我院放疗专业52项研究成果入选2023年国际顶级学术会议
2023-05-18 17:00:06
近日，美国放射肿瘤学会(American Society for Radiation Oncology, ASTRO)公布了2023年会的论文摘要录用结果，我院放疗专业共52项研究成果入选，涵盖了放射临床、放射基础、放射免疫及放射影像等前沿研究领域。其中13 项以 Oral（口头汇报）形式接收，均为于金明院士团队成果，占大会全部入选Oral的6.4%；39 项被作为Poster（壁报）接收。
美国放射肿瘤学会(American Society for Radiation Oncology, ASTRO)成立于1958年，是世界上首屈一指的放射肿瘤学组织。ASTRO年会作为全球水平最高、影响度最大的放射肿瘤领域学术活动之一，是世界放射肿瘤学界最重要的年度会议，每年都会吸引一万余名来自世界各地的相关专业人士前来参会。2023年第65届ASTRO年会将于10月1日至4日在美国圣迭戈举行。
近年来，我院有多项研究成果被ASTRO年会选定为Oral，其中2020年入选13篇，占比达5%，并于 2015 年和 2020 年两次荣获大会年度唯一的“国际优秀论文奖”。
以上成果充分展示并肯定了我院放疗学科在全球肿瘤放射治疗领域卓越的研究水平。今后，我院将会继续攻坚克难，勇攀科技高峰，力争在国内外的学术舞台上展示更多高质量的研究成果，为攻克肿瘤防治难题、守护人民群众生命健康贡献更大的力量。
入选ASTRO大会口头汇报列表
序号 | 第一作者 | 通讯作者 | 摘要信息 |
1 | 刘洁 裴金利 | Abstract #:54536 Title：Molecular imaging of radiation-induced lung injury using [18F]AlF labeled polypeptide targeting C-X-C-chemokine-receptor-type-4 Time：October 1, 8:00AM-9:00AM | |
2 | 蔡国新
| Abstract #:57589 Title：TFAM modulates cardiomyocytes pyroptosis induced by ionizing radiation through mtDNA/TLR9/NF-kB pathway Time：October 2, 10:45AM-11:45AM | |
3 | 胡晓雨 | Abstract #:56309 Title：PARP inhibitor plus radiotherapy reshapes IDH1 mutation tumor immune suppression microenvironment potentiating the efficiency of immune checkpoint inhibitor Time：October 3, 5:15PM-6:15PM | |
4 | 彭建峰 | Abstract #:55391 Title：PD-L1 inhibitors combined with thoracic radiotherapy in first-line treatment of extensive stage small cell lung cancer: a propensity score-matched, real-world study Time：October 2, 5:00PM-6:00PM | |
5 | 姚月圆 李步托
| Abstract #:56844 Title：Thoracic radiotherapy improves the outcomes of extensive stage small-cell lung cancer patients receiving first-line immunotherapy: a multicenter retrospective analysis Time：October 3, 8:00AM-9:00AM | |
6 | 陈大卫 | Abstract #:53493 Title：Safety and efficacy analysis of patients with extensive-stage small cell lung cancer (ES-SCLC) treated with SHR-1316 plus 5chemotherapy and sequential chest r6adiotherapy as first-line therapy fr7om a phase II trial Time：October 2, 5:00PM-6:00PM | |
7 | 刘旭 苑举鹏 | 陈大卫 | Abstract #:56108 Title：Irradiated Tumor Cells-derived Exosomes Modulate Macrophage Polarization by Targeting SHP-2 Mediated me-x-tabolic Reprogramming Time：October 4, 10:30AM-11:30AM |
8 | 莫忧 周甲琳 | 陈大卫 | Abstract #:54773 Title：Single-cell RNA sequencing reveals a subset of cMAS can aggravate RIHD through CXCL1-CXCR2 axis Time：October 2, 10:45AM-11:45AM |
9 | 苑举鹏 | 陈大卫 | Abstract #:55123 Title：Non-canonical NF-kB Pathway Suppresses Anti-Tumor Micro-environment and Prompts Pre-me-x-tastasis Niches for Conventional Fractionated Radiotherapy Time：October 4, 10:30AM-11:30AM |
10 | 马佳春 | 陈大卫 | Abstract #:54756 Title：A dosimetric study indicates the spinal cord irradiation contributes to acute hematologic toxicities in non-small cell lung cancer patients receiving radiotherapy combined with immunotherapy Time：October 3, 5:15PM-6:15PM |
11 | 路捷 | 陈大卫 | Abstract #:55473 Title：IKBKE promotes radioresistance of glioblastoma through AKT/FOXO3a pathway. Time：October 3, 4:00PM-5:00PM |
12 | 陈小徵 | 陈大卫 | Abstract #:55474 Title：Blocking ILT4 overcomes radio-immunotherapy treatment resistance by reversing HFRT induced CXCL1-CXCR2 axis activation and tumor-associated macrophages immunosuppression Time：October 3, 2:30PM-3:45PM |
13 | 张晶鑫 王飞 | 陈大卫 | Abstract #:56106 Title：HPK1 inhibition enhances HXRT anti -tumor immune response by regulating RGS16 to restore functionality in Tumor-infiltrating exhausted CD8+T cells Time：October 2, 10:45AM-11:45AM |
